Done sou Salè H1B

Akèy › Metiyè › Natural Sciences Managers › Boston, MA

Natural Sciences Managers nan Boston, MA: Salè H-1B

78 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Boston, MA. Salè baz medyàn ofri $122,886; mwatye mitan $92,625–$208,000.

Demann (LCA)78
Salè medyan ofri$122,886
Mwatye salè yo$92,625–$208,000
10yèm–90yèm pousantaj$78,437–$277,826

Pa nivo salè

Nivo revniSalè medyan
Nivo I (antre)$93,350
Nivo II (kalifye)$122,886
Nivo III (eksperyans)$228,405
Nivo IV (plen kompetans)$272,046

Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.

Anplwayè yo

AnplwayèLCASalè medyan
General Hospital Corporation12$89,950
Boston Medical Center Corporation12$62,232
Brigham and Women's Hospital9$93,350
Children's Hospital Corporation4$178,500
Vertex Pharmaceuticals Incorporated4$242,913
Tufts Medical Center, Inc.4$91,802
Tango Therapeutics, Inc.3$610,000
Beth Israel Deaconess Medical Center, Inc.2$101,442
Institute for Protein Innovation Inc.2$222,794
Elucid Bioimaging Inc.2$285,000
Arcaea LLC2$280,500
CRISPR Therapeutics, Inc.2$251,092
Brigham and Women's Physicians Organization, Inc2$200,000
Northeastern University2$137,894
Novotech Clinical Research USA, LLC1$124,727
Genentech, Inc.1$208,000
Syneos Health US, Inc.1$208,000
Putnam Associates, LLC1$138,790
Verily Life Sciences LLC1$140,000
Massachusetts Eye and Ear Infirmary1$95,200
Remote Technology Services, Inc.1$216,000
Dana-Farber Cancer Institute1$142,469
Seaport Therapeutics Inc1$240,000
Elektrofi, Inc.1$145,000
Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center1$221,708
TransformBio, Inc.1—
Verve Therapeutics, Inc.1$140,795
Axonis Therapeutics, Inc.1$175,000
Intrinsic Foundries, Inc.1$235,102
AIR Worldwide Corporation1$184,483

Tit travay

Pwonse H-1B nan Boston, MA →

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).